• Citer

Cutting edge: small molecule CD40 ligand mimetics promote control of parasitemia and enhance T cells producing IFN-gamma during experimental Trypanosoma cruzi infection.

par Habib, Mohammed ;Rivas, Magali Noval;Chamekh, Mostafa ;Wieckowski, Sébastien;Sun, Weimin;Bianco, Alberto;Trouche, Nathalie;Chaloin, Olivier;Dumortier, Hélène;Goldman, Michel ;Guichard, Gilles;Fournel, Sylvie;Vray, Bernard
Référence The Journal of immunology, 178, 11, page (6700-6704)
Publication Publié, 2007-06

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Host resistance to Trypanosoma cruzi infection depends on a type 1 response characterized by a strong production of IL-12 and IFN-gamma. Amplifying this response through CD40 triggering results in control of parasitemia. Two newly synthesized molecules (<3 kDa) mimicking trimeric CD40L (mini CD40Ls(-1) and (-2)) bind to CD40, activate murine dendritic cells, and elicit IL-12 production. Wild-type but not CD40 knockout mice exhibited a sharp decrease of parasitemia and mortality when inoculated with T. cruzi mixed with miniCD40Ls. Moreover, the immunosuppression induced by T. cruzi infection was impaired in mice treated with miniCD40Ls, as shown by proliferation of splenic lymphocytes, percentage of CD8(+) T cells, and IFN-gamma production. Mice surviving T. cruzi infection in the presence of miniCD40L(-1) were immunized against a challenge infection. Our results indicate that CD40L mimetics are effective in vivo and promote the control of T. cruzi infection by overcoming the immunosuppression usually induced by the parasites.